Preliminary characteristic of 45 patient of the study placebo-controlled, randomized, double-blind clinical trial to assess the safety and efficacy of using Deep Transcranial Magnetic Stimulation (EMTp) in smoking cessation.
B. Bellini,
J.R. Scholz,
D. Arnaut,
T.M.O. Abe,
R.L. Alberto,
C.L. Ferrari,
A.F. Jafet,
M.J. Teixeira,
M.A. Marcolin
Affiliations
B. Bellini
Incor (Heart Institute): Smoking Cessation Program, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil; Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil; Corresponding author.
J.R. Scholz
Incor (Heart Institute): Smoking Cessation Program, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil
D. Arnaut
Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil
T.M.O. Abe
Incor (Heart Institute): Smoking Cessation Program, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil
R.L. Alberto
Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil
C.L. Ferrari
Incor (Heart Institute): Smoking Cessation Program, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil
A.F. Jafet
Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil
M.J. Teixeira
Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil
M.A. Marcolin
Neurology Department of Clinical Hospital, Hospital das Clínicas da Faculdade de Medicina, São Paulo University, Brazil
